Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Vomiting 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Seminoma 1Nausea 1

Interventions

Dexamethasone 11Aprepitant 8Olanzapine 5ramosetron 4Palonosetron 4fosaprepitant 3Ondansetron 3Granisetron 3netupitant, palosentron drug combination 2Tropisetron 2Calcium Dobesilate 2netupitant 1lerisetron 1dexamethasone 21-phosphate 1Transcranial Direct Current Stimulation 1Tablets 1Serotonin 5-HT3 Receptor Antagonists 1Radiotherapy 1Paclitaxel 1Music Therapy 1Metoclopramide 1Megestrol Acetate 1Megestrol 1Gelatin 1Dronabinol 1Dosage Forms 1Carboplatin 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Vomiting × lerisetron × Clear all
NCT00004219 2013-08-02

Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men Being Treated With Radiation Therapy for Stage I Seminoma

National Cancer Institute (NCI)

Phase 3 Unknown
150 enrolled
Genitourinary

Testicular Germ Cell Tumor, Nausea, Testicular Neoplasms, Vomiting, Seminoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡